ARAAX
Price
$25.69
Change
-$1.20 (-4.46%)
Updated
Feb 3 closing price
Net Assets
1.46B
DRRCX
Price
$16.71
Change
+$0.70 (+4.37%)
Updated
Feb 3 closing price
Net Assets
864.59M
Interact to see
Advertisement

ARAAX vs DRRCX

Header iconARAAX vs DRRCX Comparison
Open Charts ARAAX vs DRRCXBanner chart's image
Horizon Active Risk Assist® A
Price$25.69
Change-$1.20 (-4.46%)
VolumeN/A
Net Assets1.46B
BNY Mellon Global Real Return - C
Price$16.71
Change+$0.70 (+4.37%)
VolumeN/A
Net Assets864.59M
ARAAX vs DRRCX Comparison Chart in %
View a ticker or compare two or three
VS
ARAAX vs. DRRCX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAAX is a Hold and DRRCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARAAX has more cash in the bank: 1.46B vs. DRRCX (865M). DRRCX pays higher dividends than ARAAX: DRRCX (2.84) vs ARAAX (0.54). ARAAX was incepted earlier than DRRCX: ARAAX (10 years) vs DRRCX (16 years). DRRCX (2.00) is less costly to investors than ARAAX (1.43). DRRCX is a more actively managed with annual turnover of: 119.04 vs. ARAAX (66.00). DRRCX has a lower initial minimum investment than ARAAX: DRRCX (1000) vs ARAAX (2500). DRRCX annual gain was more profitable for investors over the last year : 15.47 vs. ARAAX (5.57). DRRCX return over 5 years is better than : 19.74 vs. ARAAX (12.56).
ARAAXDRRCXARAAX / DRRCX
Total Expense Ratio1.431.9374%
Annual Report Gross Expense Ratio1.432.0072%
Fund Existence10 years16 years-
Gain YTD2.7195.02854%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B865M168%
Annual Yield % from dividends0.542.8419%
Returns for 1 year5.5715.4736%
Returns for 3 years24.6126.2994%
Returns for 5 years12.5619.7464%
Returns for 10 years52.8048.74108%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYLN2.150.05
+2.38%
Hyliion Holdings Corp
MBNKO25.460.15
+0.59%
Medallion Bk
ANIP79.88-0.12
-0.15%
ANI Pharmaceuticals
KNSL391.77-1.45
-0.37%
Kinsale Capital Group
IBO0.51-0.01
-2.09%
Impact BioMedical Inc.